# Exparel for Postoperative Pain Management in Shoulder Surgery

> **NCT02472314** · PHASE4 · COMPLETED · sponsor: **Wayne State University** · enrollment: 70 (actual)

## Conditions studied

- Fracture of Shoulder and Upper Arm

## Interventions

- **DRUG:** 1.3% Liposomal Bupivacaine
- **DRUG:** 0.125% Bupivacaine

## Key facts

- **NCT ID:** NCT02472314
- **Lead sponsor:** Wayne State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02472314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02472314, "Exparel for Postoperative Pain Management in Shoulder Surgery". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02472314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*